Patent intelligence · US
US 12133831
Kits for preparing and delivering purified corticotropin
Kits for preparing and delivering purified corticotropin
Patent details — US 12133831
- Jurisdiction
- US
- Status
- granted
- Grant date
- Nov 5, 2024
- Expiration
- Oct 31, 2044
- Applicant
- ANI Pharmaceuticals, Inc.
- Claims
- 20
- CPC classes
- A61K, A61K38/22, A61K38/2228, A61K38/35
Quick answer
US 12133831 (Kits for preparing and delivering purified corticotropin) is held by ANI Pharmaceuticals, Inc.. Status: granted. Granted Nov 5, 2024. Expires Oct 31, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- ANI Pharmaceuticals, Inc.
- Grant date
- Expiration
- Claims
- 20
- CPC classes
- A61K, A61K38/22, A61K38/2228, A61K38/35, A61K47/10, A61K47/42
More from ANI Pharmaceuticals, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12350245
Stable oral suspensions of baclofen
granted -
US 12324787
Kits for preparing and delivering purified corticotropin
granted -
US 12233105
Methods for storing and warming purified corticotropin compositions
granted -
US 12102662
Methods for storing and warming purified corticotropin compositions
granted -
US 11975047
Methods for storing and warming purified corticotropin compositions
granted -
US 11857524
Stable oral suspensions of baclofen
granted
Frequently asked questions
What is US patent 12133831?
US 12133831 (Kits for preparing and delivering purified corticotropin) is held by ANI Pharmaceuticals, Inc.. Status: granted. Granted Nov 5, 2024. Expires Oct 31, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 12133831?
ANI Pharmaceuticals, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 7 pharmaceutical patents for this assignee.
When does US 12133831 expire?
Our index shows an expiration date of Oct 31, 2044 (18 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.